Can-Fite BioPharma Ltd.

CANF | AMEX

Price Alert Chart Builder DCF Calculator

$2.22

-$0.02 (-0.89%)

At close: Sep 21, 2026, 4:00 PM ET

$2.26

+$0.04 (+1.74%)

Pre-market: Sep 22, 2026, 6:16 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021	Q4 2020 Dec 30, 2020	Q3 2020 Sep 29, 2020	Q2 2020 Jun 29, 2020	Q1 2020 Mar 30, 2020
Revenue	560K	617K	674K	650K	667K	705K	743K	785K	793K	801K	810K	817K	864K	910K	853K	799K	759K	713K	763K	805K	1.75M	1.93M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	560K	617K	674K	650K	667K	705K	743K	785K	793K	801K	810K	817K	864K	910K	853K	799K	759K	713K	763K	805K	1.75M	1.93M
Operating Income	-8.93M	-8.53M	-8.13M	-7.95M	-7.79M	-7.53M	-8.2M	-9.44M	-10.15M	-10.44M	-10.22M	-11.17M	-12.11M	-13.17M	-12.84M	-12.37M	-11.34M	-12.03M	-14.14M	-15.19M	-15.51M	-14.57M
Interest Income	176K	233.5K	291K	341K	370K	412.5K	506K	742K	680K	569K	407K	44K	110K	110K	403K	424K	314K	314K	21K	9K	36K	63K
Pretax Income	-8.8M	-8.34M	-7.88M	-7.57M	-7.37M	-7.06M	-7.63M	-9M	-9.77M	-10.29M	-10.17M	-11.27M	-12.14M	-13.17M	-12.62M	-12.13M	-11.31M	-11.98M	-14.44M	-12.56M	-12.93M	-12.1M
Net Income	-8.8M	-8.34M	-7.88M	-7.57M	-7.37M	-7.06M	-7.47M	-8.78M	-9.45M	-10.22M	-10.39M	-11.55M	-12.51M	-13.3M	-12.62M	-12.13M	-11.31M	-11.98M	-14.44M	-12.56M	-12.93M	-12.1M
Selling & General & Admin	3.59M	3.32M	3.05M	3.01M	3.01M	2.87M	2.96M	3.06M	3.04M	3.24M	3.14M	3.45M	3.53M	3.58M	3.85M	3.52M	3.39M	3.26M	2.95M	2.88M	3.07M	3.09M
Research & Development	5.91M	5.83M	5.76M	5.59M	5.45M	5.36M	5.98M	7.17M	7.91M	8M	7.76M	8.41M	9.31M	10.37M	9.85M	9.65M	8.71M	9.48M	11.95M	13.02M	14.07M	13.3M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	107K	107K	107K
Operating Expenses	9.49M	9.15M	8.8M	8.6M	8.46M	8.24M	8.94M	10.23M	10.95M	11.24M	10.91M	11.86M	12.84M	13.95M	13.7M	13.17M	12.1M	12.75M	14.9M	16M	17.25M	16.5M
Interest Expense	n/a	n/a	n/a	14K	17K	17K	17K	19K	16K	137K	201K	500K	500K	465K	401K	225K	321K	297K	363K	253K	341K	473K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.49M	9.15M	8.8M	8.6M	8.46M	8.24M	8.94M	10.23M	10.95M	11.24M	10.91M	11.86M	12.84M	13.95M	13.7M	13.17M	12.1M	12.75M	14.9M	16M	17.25M	16.5M
Income Tax Expense	n/a	n/a	n/a	n/a	-3.5K	-7.5K	-169.5K	-233.5K	-318K	-72K	218K	282K	367K	121K	-10K	-10K	-10.5K	-9.5K	-10K	-10K	17K	43K
Shares Outstanding (Basic)	11.38M	11.38M	8.44M	8.44M	6.07M	6.07M	4.95M	4.08M	4.09M	3.93M	2.72M	2.72M	2.72M	2.72M	1.36M	1.83M	1.72M	1.61M	1.55M	1.53M	1.03M	576.51K
Shares Outstanding (Diluted)	11.37M	11.37M	8.44M	8.44M	6.07M	6.07M	4.95M	4.08M	4.08M	3.93M	2.72M	2.72M	2.72M	2.72M	2.22M	1.83M	1.72M	1.61M	1.55M	1.53M	1.03M	671.45K
EPS (Basic)	-0.90	-1.02	-1.14	-1.23	-1.41	-1.50	-1.83	-2.61	-3.12	-3.51	-3.75	-5.67	-6.60	-7.65	-7.92	-7.23	-7.05	-8.97	-15.33	-24.06	-33	-42
EPS (Diluted)	-0.90	-1.02	-1.14	-1.23	-1.41	-1.50	-1.83	-2.61	-3.12	-3.51	-3.75	-5.67	-6.60	-7.65	-7.92	-7.23	-7.05	-8.97	-15.33	-24.06	-33	-42
EBITDA	-8.91M	-8.51M	-8.12M	-7.94M	-7.78M	-7.52M	-8.18M	-9.43M	-10.14M	-10.42M	-10.08M	-11.03M	-11.96M	-13.03M	-12.83M	-12.35M	-11.32M	-12.02M	-14.13M	-15.18M	-15.47M	-14.51M
EBIT	-8.93M	-8.53M	-8.13M	-7.95M	-7.79M	-7.53M	-8.2M	-9.44M	-10.15M	-10.44M	-10.1M	-11.04M	-11.98M	-13.04M	-12.84M	-12.31M	-11.28M	-11.98M	-14.08M	-12.41M	-12.69M	-11.73M
Depreciation & Amortization	29K	18K	7K	7.75K	8.25K	11.75K	14.75K	14.5K	14.5K	13.5K	13.5K	13.5K	13K	14K	13.5K	13K	13.5K	12.5K	13K	13.5K	13.5K	14.5K